Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Kimmtrak: Groundbreaking Immuno-Oncological Treatment for Metastatic Uveal Melanoma
Tebentafusp is a pharmacological breakthrough in the fight against a deadly disease.
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience
Even Severe Multiple Sclerosis Can Be Cured
Atara Biotherapeutics and its awesome T-cell therapy against Epstein–Barr virus can really cure progressive forms of multiple sclerosis.
Posted inInfections, Pharma & Biotech
Sanofi to Make Vaccine Against Acne
Acne vulgaris treatment will reach a new level of quality.
Posted inMergers & Acquisitions, Oncology
Takeda Bets on Promising Gamma Delta T-cell Immunotherapy
UK-based GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies.
Posted inAutoimmune Diseases, Clinical Trials, Metabolism
Precigen ActoBio: Innovative Treatment for Type 1 Diabetes Mellitus
The autoimmune disease will be defeated by restoring immune tolerance.
Posted inOncology, Regulatory
Opdivo and Keytruda: First-line Immunotherapy for Gastric Cancer and Esophageal Cancer
Nivolumab or pembrolizumab should be added to standard chemotherapy to prolong the life of patients with gastric, esophageal, and gastroesophageal junction cancers.